Peter Simpson Tests the New SelectScience

Hear what the Director of the N8 Research Partnership thinks

23 Mar 2015
David Perrett
Other (please specify)

Dr Peter Simpson, Director, N8 Research Partnership

As Director of the N8 Research Partnership, the collaboration of the eight most research intensive universities in the North of England, Dr Peter Simpson is involved in overseeing collaborative research programs, as well as building and developing new academic-industrial research initiatives and multi-institution collaborations.

Prior to joining the N8 Research Partnership, Dr Simpson worked for AstraZeneca from 2006 to 2014, where he led life sciences research departments and project teams.

Part of Peter’s role is to be up-to-date with new technology and the best equipment to purchase for the research-intensive universities involved in the N8 Research Partnership: "I need to stay informed on state-of-the-art developments," he said.

Researching the Latest Technologies

As part of Peter’s role, he has to research the most suitable technologies for a range of different labs and collaborations, in rapidly innovating fields such as NMR products, and mass spectrometry, before looking to purchase large pieces of equipment within the overall N8 strategy. Peter uses the SelectScience Buying Guides to keep up-to-date with the latest technologies and trends, and discover which products may be of most use to his work.


I have used SelectScience to find out about methods, equipment and products in fields I don’t have personal expertise in

 


Peter Simpson

N8 Research Partnership

About the N8 Research Partnership

The N8 Research Partnership is a not-for-profit company that is a collaboration of the eight most research-intensive universities in the north of England. It aims to maximize the impact of this research base by identifying and coordinating powerful research teams and collaborations. Among the N8 Research Partnership's main research areas are industrial biotechnology, life sciences, food security and technology, and regenerative medicine.

Why SelectScience?

Peter has used SelectScience over the past 18 months to make decisions about new technologies in his previous role within AstraZeneca. “I use SelectScience to find out about methods, equipment and products I don’t have personal knowledge about,” he said.

Beta Testing the New SelectScience Website...

Likes

  • I appreciate the amount of information.
  • The search bar is really obvious and really useful.
  • I like the Events page; I hadn’t seen this before on the previous site.

Recommendations

  • Would like the products grouped by supplier within each technique or application area.
  • A way to communicate to younger members of the SelectScience communities.

"Many thanks to Peter for beta-testing our new website. His recommendations are already being worked on by our team!" Kerry Parker, Editor-in-Chief

Learn more about the N8 Research Partnership
Find out more about Peter

Links

Tags